Publications by authors named "Judith Neukirchen"

Claim this Profile
M
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Maximilian Stahl, Rory M Shallis, Wei Wei, Pau Montesinos, Etienne Lengline, Judith Neukirchen

Leukemia· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.
Rory M Shallis, Maximilian Stahl, Wei Wei, Pau Montesinos, Etienne Lengline, Judith Neukirchen

Leuk Lymphoma· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort.
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, Judith Neukirchen, Mikkael A Sekeres

Blood Adv· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
Judith Neukirchen, Michael Lauseker, Barbara Hildebrandt, Ann-Christin Nolting, Jennifer Kaivers

Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study evaluating the impact of infectious complications during azacitidine treatment.
Anna Schuck, Marie-Christine Goette, Judith Neukirchen, Andrea Kuendgen, Norbert Gattermann

Ann Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.
Louise de Swart, Alex Smith, Marius MacKenzie, Argiris Symeonidis, Judith Neukirchen

Ann Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.
Blanca Xicoy, Ulrich Germing, María-José Jimenez, Olga Garcia, Regina Garcia, Judith Neukirchen

Eur J Haematol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Jennifer Schemenau, Stephan Baldus, Martin Anlauf, Petra Reinecke, Stefan Braunstein, Judith Neukirchen

Eur J Haematol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change of prognosis of patients with myelodysplastic syndromes during the last 30 years.
Judith Neukirchen, Kathrin Nachtkamp, Jennifer Schemenau, Carlo Aul, Aristoteles Giagounidis

Leuk Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system.
Esther Zipperer, Nina Tanha, Corinna Strupp, Andrea Kündgen, Kathrin Nachtkamp, Judith Neukirchen

Haematologica· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron chelation in MDS: still a controversial issue.
Judith Neukirchen

Leuk Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow.
Judith Neukirchen, Uwe Platzbecker, Katja Sockel, Antonis Tsamaloukas, Rainer Haas

Ann Hematol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study.
Judith Neukirchen, Michael Lauseker, Sabine Blum, Aristoteles Giagounidis, Michael Lübbert

Leuk Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed score for survival of patients with myelodysplastic syndromes.
Wolfgang R Sperr, Michael Kundi, Friedrich Wimazal, Thomas Nösslinger, Anabel Schönmetzler-Makrai, Judith Neukirchen

Eur J Clin Invest· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to treat patients with CMML?
Ulrich Germing, Judith Neukirchen

Leuk Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry.
Judith Neukirchen, Frank Fox, Andrea Kündgen, Kathrin Nachtkamp, Corinna Strupp

Leuk Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.
Judith Neukirchen, Wilma M Schoonen, Corinna Strupp, Norbert Gattermann, Carlo Aul

Leuk Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid.
Andrea Kuendgen, Gesine Bug, Oliver G Ottmann, Detlef Haase, Julie Schanz, Judith Neukirchen

Clin Epigenetics· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
Judith Neukirchen, Sabine Blum, Andrea Kuendgen, Corinna Strupp, Manuel Aivado

Eur J Haematol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic molecular markers in myelodysplastic syndromes.
Judith Neukirchen, Rainer Haas, Ulrich Germing

Expert Rev Hematol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.
Astrid Rohrbeck, Judith Neukirchen, Michael Rosskopf, Guillermo G Pardillos, Helene Geddert

J Transl Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.
Nina Rehfeld, Helene Geddert, Abedelsalam Atamna, Astrid Rohrbeck, Guillermo Garcia, Judith Neukirchen

J Carcinog· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles.
Ulrich-Peter Rohr, Florian Heyd, Judith Neukirchen, Marc-Andre Wulf, Iris Queitsch

J Virol Methods· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis